Takeda to Divest Four Diabetes Products in Japan to Teijin Pharma Limited pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Posted on 234
BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of a new plasma center in Moreno Valley, CA, to help meet the urgent need for plasma donations which has become even greater during the pandemic. Plasma donations received at BioLife centers are used by Takeda to make established therapies that treat a range of rare and complex conditions for which there is often no alternative treatment. This is the first BioLife center to open in California, with the next centers opening in Rialto, Corona and Riverside.
“Our expansion into California is part of BioLife’s mission as a leader in plasma donation to grow our network and address an urgent need for life-saving plasma used to develop therapies for people around the world,” said Hema Tallman, Global Head of BioLife Operations. “Plasma-based therapies are a lifeline for thousands of people with rare,
Updated:
Share Article
AAA
Health Minister C. Vijayabaskar at the manufacturing unit II of Tamil Nadu Medicinal Plant Farms and Herbal Medicine Corporation Limited in Pudukottai on Thursday.
| Photo Credit: HAND OUT
The foundation stone for a new government dental college and hospital, to be established at Pudukottai Government Medical College campus, was laid on Thursday. Health Minister C. Vijayabaskar, who laid the foundation stone, said the institution would come up in an area of 10.14 acres and the college and hospital buildings would be built at a cost of ₹63.41 crore. The ground plus first floor buildings would have modern amenities. The college would also have separate hostels for men and women students.
TOKYO (dpa-AFX) - Takeda Pharmaceutical Company Limited (TAK) said Wednesday that the first subject was dosed in its Phase 1/2 immunogenicity and safety study of Novavax' COVID-19 vaccine candidate
36
Global Addison’s Disease drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period.
The worldwide Addison’s Disease Drugs market report gives precise and thorough information about prospective and existing customers, the competition, and the industry in general as it is the foundation of all successful business ventures. A supreme market data and insights allows business owners to determine the feasibility of a business before committing substantial resources to the venture. Market research report encompasses relevant data to help solve marketing challenges that a business will most likely face which is an integral part of the business planning process. By using Addison’s Disease Drugs market document, clients can outperform competitors using accurate and up-to-date demand-side dynamics information.